ロード中...
Transcriptomic Signatures of Auger Electron Radioimmunotherapy Using Nuclear Targeting (111)In-Trastuzumab for Potential Combination Therapies
(111)In-labeled trastuzumab modified with nuclear localizing signal (NLS) peptides ((111)In-trastuzumab-NLS) efficiently delivers an Auger electron (AE) emitter (111)In into the cell nucleus and is thus a promising radiopharmaceutical in AE radioimmunotherapy (AE-RIT) for targeted killing of HER2-po...
保存先:
| 出版年: | Cancer Biother Radiopharm |
|---|---|
| 主要な著者: | , , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Mary Ann Liebert, Inc.
2015
|
| 主題: | |
| オンライン・アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4601633/ https://ncbi.nlm.nih.gov/pubmed/26447839 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1089/cbr.2015.1882 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|